Kintara Therapeutics to Present at the Emerging Growth Conference
SAN DIEGO, Aug. 9, 2023 /PRNewswire/ — Kintara Therapeutics, Inc. (Nasdaq: KTRA) (“Kintara” or the “Company”), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced that its President and CEO, Robert E. Hoffman will present in the…
Comments Off on Kintara Therapeutics to Present at the Emerging Growth Conference